Identification of novel anticancer terpenoids from Prosopis juliflora (Sw) DC (Leguminosae) pods
Purpose: To identify a novel source of terpenoid anticancer compounds from P. juliflora (Sw.) DC. (Leguminosae) pods as a medicinal substitute for cancer medicines.
Methods: The pods were collected, dried and pulverized. The ethanol extract was prepared by maceration. Various phyto-constituents were detected in the extract by UV-VIS spectroscopy at a wavelength ranging from 200 - 800 nm. The molecular formula, chemical structure, and percent peak area of these phyto-constituents were determined by gas chromatography-mass spectrometry (GC-MS). attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) was used for functional group determination of bioactive compounds.
Results: P. juliflora pods were rich in tannins, carotenoid and terpenoids. Nineteen bioactive compounds were detected. Out of these, thirteen are here reported for the first time with four of them exhibiting anticancer activities, while two belong chemically to terpenoids. Furthermore, FTIR established characteristic peaks for the various biologically-active functional groups.
Conclusion: The results show that P. juliflora pods is a valuable source of anticancer, antitumor and chemoprotective compounds, especially terpenoids, that can potentially be developed as alternatives to current painful and costly cancer therapies.
Keywords: Prosopis juliflora (Sw.) DC., Anticancer terpenoids, Attenuated total reflectance-FTIR, Herbal medicine
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.